Microscopy

ZEISS Academy Africa inaugurated

Retrieved on: 
Friday, December 9, 2022
German, Partnership, STEM, CFO, ZEISS, Jumpstart Academy Africa, Economy, Microscopy, African, Student, National Association Medical Staff Services, Pharmaceutical industry

JOHANNESBURG, Dec. 9, 2022 /PRNewswire/ -- During his visit to Namibia and to South Africa this week, the German Federal Minister for Economic Affairs and Climate Action, Robert Habeck, joined the CFO of Carl Zeiss Meditec AG Justus Felix Wehmer and ZEISS South Africa head Seyfi Ceyhan for the inauguration of the ZEISS Academy Africa at the company's regional headquarters in Johannesburg.

Key Points: 
  • JOHANNESBURG, Dec. 9, 2022 /PRNewswire/ --During his visit to Namibia and to South Africa this week, the German Federal Minister for Economic Affairs and Climate Action, Robert Habeck, joined the CFO of Carl Zeiss Meditec AG Justus Felix Wehmer and ZEISS South Africa head Seyfi Ceyhan for the inauguration of the ZEISS Academy Africa at the company's regional headquarters in Johannesburg.
  • With a one million euro investment in equipment and facilities, the ZEISS Academy Africa is an important step to strengthen the presence of the company in South Africa and Sub-Saharan Africa.
  • Doctors and medical staff, engineers and researchers have access to hands-on training under near real-life conditions utilizing the most current ZEISS product portfolio.
  • The Academy Africa also supports children and youth, especially from underprivileged areas, giving them access to microscopy and encouraging them to get into STEM subjects.

Photonic Advances Enhance Imaging Techniques

Retrieved on: 
Tuesday, November 29, 2022
Technology, Biotechnology, Nanotechnology, Audio, Video, Health, Radiology, Optical, Philanthropy, Oncology, Other Science, Research, Medical Devices, Foundation, Science, Magnet, ICFO, Skin, Environment, Science, Electronics, Microscopy, Shanghai Jiao Tong University, Engineering, University, DIC, Health care, Nanostructure, OCT, Student, Acquisition, Knowledge, Virtual reality, Movement, OSA, Capillary, Nanyang Technological University, History of magnetic resonance imaging, Maintenance, Silicon, Thought, MRI, Neoplasm, Optical coherence tomography, CT scan, Health, Research, Element, Publication, CT, SWH, Light, Microscope, Medical imaging, Optica

The field of imaging has benefited greatly from advances in photonics, said Majid Ebrahim-Zadeh, ICFO - Institut de Ciencies Fotoniques, Spain, and member of the 20th Anniversary Challenge Selection Committee.

Key Points: 
  • The field of imaging has benefited greatly from advances in photonics, said Majid Ebrahim-Zadeh, ICFO - Institut de Ciencies Fotoniques, Spain, and member of the 20th Anniversary Challenge Selection Committee.
  • The research being conducted by the challenge recipients strives to solve for todays pain points in imaging, including efficiency and accessibility.
  • Im trying to revolutionize existing microscopic techniques with new and advanced optical elements based on metasurfaces, explains Hu.
  • Over the last decades, the field of medical imaging has spawned several seminal inventions, including Optical Coherence Tomography (OCT), Computed Tomography (CT), ultrasound, and Magnet Resonance Imaging (MRI).

Medical Image Analysis Software Global Market Report 2022: Ukraine-Russia War Impact

Retrieved on: 
Friday, November 25, 2022
INFINITT Healthcare, Canon Medical Systems Corporation, World Health Organization, Conditional sentence, Elective surgery, Cancer, Acquisition, Internet, GE Healthcare, Growth, 3D, Prevalence, Hospital, Software, Philips, PET, Research, COVID-19, Incidence, Gynaecology, MRI, Society, Tomography, Diabetes, 2D, CT, Neurology, Radiology, Obstetrics, Chronic condition, Siemens Healthineers, Mammography, Collection, MICE, Cardiology, Microscopy, Medical imaging, Pharmaceutical industry

The medical image analysis software market is expected to grow to $4.56 billion in 2026 at a CAGR of 9.1%.

Key Points: 
  • The medical image analysis software market is expected to grow to $4.56 billion in 2026 at a CAGR of 9.1%.
  • The medical image analysis software market consists of the sales of medical image analysis software by entities (manufacturers, sole traders, and partnerships) that are used to enhance the efficiency of the chosen medical treatment by examining, training, storing, and exchanging medical data.
  • Major companies operating in the medical image analysis software market are focused on developing technologically advanced software solutions to strengthen their market position.
  • The medical image analysis market research report is one of a series of new reports that provides medical image analysis market statistics, including medical image analysis industry global market size, regional shares, competitors with a medical image analysis market share, detailed medical image analysis market segments, market trends and opportunities, and any further data you may need to thrive in the medical image analysis industry.

Microscopy Global Market Report 2022: Rising Focus on Nanotechnology & Regenerative Medicine for Various Chronic Diseases Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 24, 2022
Technology, Science, Hardware, Research, Confocal, Nanotechnology, AFM, Optics, Region, USD, TEM, Software, STM, Stereophonic sound, Research, Regenerative medicine, Electron microscope, SEM, Microscopy, Microscope

The "Microscopy Market by Product (Software, Microscope, Accessories), Type (Optical, Stereo, Confocal, Microscope), Electron Microscope (TEM, SEM, STM, AFM), by Application (Life Science, Semiconductor), by End User (Research, Industrial) and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Microscopy Market by Product (Software, Microscope, Accessories), Type (Optical, Stereo, Confocal, Microscope), Electron Microscope (TEM, SEM, STM, AFM), by Application (Life Science, Semiconductor), by End User (Research, Industrial) and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • The global microscopy market is estimated to be USD 7,612.4 million in 2021 and is expected to witness a CAGR of 6.89% during the forecast period.
  • Favourable funding scenario for R&D in microscopy from various public and private investors, technological advancements in microscopes, and rising focus on nanotechnology & regenerative medicine for various chronic diseases are the major factors driving the global microscopy market.
  • However, the market growth can be hindered by the high cost of advanced microscopes in the developing economies and dearth of skilled professionals.

Biophotonics Global Market Report 2022: Featuring Becton, Dickinson & Co, Affymetrix, Carl Zeiss,Olympus America, Andor Technology & Hamamatsu Photonics - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 22, 2022
Health, General Health, Region, Marketing, Washington Manual of Medical Therapeutics, Application, Analytical chemistry, US, Microscopy, Renewable energy, Medical device, Biophotonics

Based on application, market is segmented into see through imaging, inside imaging, spectro molecular, surface imaging, microscopy, light therapy, biosensors, and other analytic sensing.

Key Points: 
  • Based on application, market is segmented into see through imaging, inside imaging, spectro molecular, surface imaging, microscopy, light therapy, biosensors, and other analytic sensing.
  • Furthermore, based on end use, biophotonics market is segmented into medical diagnostics, medical therapeutics, test components, and non-medical applications.
  • Based on end use, medical diagnostics accounted for the largest revenue share in the global biophotonics market, followed by medical therapeutics and test components.
  • Among region, North America held dominant position in the global biophotonics market, followed by Europe and Middle East & Africa.

Circulating Tumor Cells (CTC) Global Market Report 2022: Featuring BioFluidica, Fluxion Biosciences, Menarini Silicon Biosystems & More - ResearchAndMarkets.com

Retrieved on: 
Monday, November 21, 2022
Health, Oncology, Lung, Prevalence, Blood, R, Liquid biopsy, Nanotechnology, Bachelor of Engineering, Drug development, Prostate cancer, Patient, Cancer, Research, Primary tumor, COVID-19, Diagnosis, MI, Fortis Healthcare, Metastasis, Breast, Microscopy, CTC, Medical imaging, Growth

The "Circulating Tumor Cells (CTC) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Circulating Tumor Cells (CTC) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global circulating tumor cells (CTC) market size reached US$ 9.54 Billion in 2021.
  • Circulating tumor cells (CTC) are cancer cells that split away from the primary tumor and appear in the circulatory system as singular units or clusters.
  • Circulating Tumor Cells (CTC) Market Trends:
    increasing prevalence of cancer due to genetic disorders, rising alcohol consumption, and rapid lifestyle changes are key factors driving the market growth.

NanoVibronix Announces Interim Results of Clinical Study for UroShield

Retrieved on: 
Wednesday, November 16, 2022
Health, Medical Devices, Health Technology, Clinical Trials, Research, Science, Biotechnology, FDA, Sale, Trial of the century, Clinical trial, Risk, Trademark dilution, SAW, University, Culture, Research, Security (finance), Documentation, Biofilm, University of Southampton, Urine, Infection, Microscopy, Patient, Pharmaceutical industry, Medical imaging, Medical device

NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced interim results of its U.K. clinical study for UroShield that is being conducted by The University of Southampton and the National Biofilms Innovation Centre.

Key Points: 
  • NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced interim results of its U.K. clinical study for UroShield that is being conducted by The University of Southampton and the National Biofilms Innovation Centre.
  • Brian Murphy, CEO of NanoVibronix, stated, We are encouraged by the interim results we received from the Southampton quantitative and qualitative study for UroShield.
  • Initial results of the independent, real world patient study suggest changes in the microbial population diversity following use of the Uroshield, with potential beneficial effects on the urinary and catheter microbiome.
  • In addition to these analyses, most patients using the Uroshield reported fewer catheter blockages and infections, and other positive benefits.

Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio

Retrieved on: 
Monday, November 14, 2022
General Health, Neurology, Other Health, Health, Health Technology, B cell, Entrepreneurship, Animal, Proteomics, Machine learning, Bruker, Life, Corporation, Research, Acquisition, Optogenetics, Central nervous system, Neuron, Ultima, Cell biology, Microscopy, Microscope

This platform creates strong synergies with Brukers existing Ultima multiphoton solutions and newly acquired Inscopix head-mounted miniscopes.

Key Points: 
  • This platform creates strong synergies with Brukers existing Ultima multiphoton solutions and newly acquired Inscopix head-mounted miniscopes.
  • Our differentiated system provides a viable means of performing multi-region-of-interest investigation with minimal weight impact to subject animals, said Dr. Yasaman Soudagar, Co-Founder and CEO of Neurescence.
  • Now, with Bruker, we can greatly increase the worldwide reach of this technology to enable researchers to gain deeper knowledge of neural network functions.
  • Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life.

Entrupy's "State of the Fake" Showcases Latest Trends in Product Counterfeiting, Debuts Insights on Most Faked Sneaker Styles

Retrieved on: 
Thursday, November 17, 2022
Algorithm, Ecosystem, Trust, Accounting, Yeezy, Goyard, VC, Monogram, Organization, Cloud computing, Sale, Law enforcement, Software as a service, Microscopy, Risk, Meta, AI, Jordans, Online shopping, Security printing

NEW YORK,  November 17, 2022 /PRNewswire-PRWeb/ -- Product verification and identification technology company Entrupy today released the "State of the Fake 2022," a report that provides unique insights into the murky world of counterfeit products and how the company and industry overall are working to combat it.

Key Points: 
  • For sneakers, the rate of unidentified items found since Entrupy began authentications in 2021 is approximately 16 percent.
  • For Vietnam and Philippines, the elevated incidences could be connected to their proximity to production centers in China.
  • The iconic Neverfull tote bag in the brand's signature Monogram canvas material continued to be the most authenticated style.
  • These authentications are performed by Entrupy's business customers including e-commerce marketplaces, pawnshops and resellers that operate in the secondary market.

Bruker Announces Quarterly Dividend

Retrieved on: 
Friday, November 11, 2022
Science, Biotechnology, Research, Pharmaceutical, Health, Medical Devices, Infectious Diseases, Clinical Trials, U.S. Securities and Exchange Commission, Securities Act of 1933, Board of directors, Microscopy, Risk, Annual report, Board, Securities Exchange Act of 1934, Security (finance), Life, Research, Cell biology, Solution, Bruker, Proteomics, Corporation, SEC, Form 10-Q, Nasdaq, Form 10-K

Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Companys common stock.

Key Points: 
  • Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Companys common stock.
  • The dividend will be paid on December 16, 2022 to stockholders of record as of December 1, 2022.
  • Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life.
  • Brukers high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.